News

Passwords Are No Longer Required To Sign Into Google Accounts

Google will allow users to replace passwords and 2FA with passkeys.

Published

1 year ago

May 4, 2023

Nour Nasir

Google

Google has taken a step towards a passwordless future, announcing that passkey functionality is being added to all Google accounts.

Passkeys are cryptographic tools that allow users to ditch passwords and two-factor verification when signing in. Google, along with Apple and Microsoft, are keen to push the technology, which uses a local PIN or a device’s biometric tools such as fingerprint scanners or Face ID.

Biometric data from passkeys isn’t shared with third parties and only exists on a user’s device, providing enhanced security since no passwords can be hacked or stolen.

When a passkey is added to a Google account, users will be prompted for it on new sign-ins or when potentially suspicious activity is detected. Passkeys can be stored on any compatible hardware, including iPhones with iOS 16 and Android devices running Android 9 and above. Users can access passkeys on other devices by using services such as iCloud or password managers like 1Password. In addition, Google also allows the following:

Accounts can be accessed temporarily using someone else’s device by selecting “use a passkey from another device” to create a one-time sign-in.
Passkeys can be revoked immediately in the account settings section if a user suspects a security breach, or a device is lost or stolen.
Users of Google’s Advanced Protection Program (a free service providing additional security against phishing and malware) can use passkeys instead of physical security keys.

Also Read: Abu Dhabi Scientists Create Electronic Appetite Regulation Pill

If you’d prefer to log in to your account the traditional way, Google will continue to support regular passwords for the foreseeable future, allowing users without a biometric device to make the change once they eventually upgrade their hardware.

News

Orchid Plans To Find Out What’s Wrong With You Before You’re Born

According to CEO Noor Siddiqui, the company isn’t on a mission to make designer babies, but aims to beat genetic odds and relieve suffering.

Published

13 hours ago

May 7, 2024

Nour Nasir

Orchid

Each day, around 400,000 babies are welcomed into the world. However, among those, a growing number will experience some kind of birth defect or inherited disease.

Noor Siddiqui, CEO of Orchid, hopes to “mitigate” unpleasant genetic surprises using genome sequencing technology to reveal a wealth of genetic information on which newborns will grow into healthy adults.

Until 2019, IVF specialists had access to under 1% of the human genome. The tests, called PGT-A and PGT-M, scanned a mere 1,000 data points in a genome comprising around 3 billion bases, offering a very limited dataset compared to the technology used by Orchid.

“Our chromosomes are like chapters in a book that make up the table of contents.” Explained Siddiqui. “[PGT-A and PGT-M tests] only examine the table of contents, whereas what Orchid is doing is like a spellcheck on the entire book.” Orchid’s genome sampling technology assesses “100 times the data, covering many more conditions.” In essence, an Orchid report covers three categories of common genetic issues: monogenic disorders, polygenic conditions, and de-novo mutations.

Also Read: Advancing MENA Health Through AI Vascular Age Analysis

Orchid’s technology raises many questions. Aside from the obvious ethical concerns, data privacy is the most obvious potential issue with the tests. Noor Siddiqui is keen to alleviate any concerns: “No data at Orchid is ever sold to any third parties. Parents are in complete control of their data. If they want to delete the data, we’re happy to delete it off of our servers. If they want to export the data, they can export the data. And if they want us to re-analyze the data, we can re-analyze the data”.

Compared to a lifetime of medical bills, gene therapy, and suffering, Orchid’s genome screening report has the potential to change the future lives of thousands of newborns worldwide.